138 related articles for article (PubMed ID: 16401782)
1. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study.
McGwin G; Modjarrad K; Hall TA; Xie A; Owsley C
Arch Ophthalmol; 2006 Jan; 124(1):33-7. PubMed ID: 16401782
[TBL] [Abstract][Full Text] [Related]
2. The use of cholesterol-lowering medications and age-related macular degeneration.
McGwin G; Xie A; Owsley C
Ophthalmology; 2005 Mar; 112(3):488-94. PubMed ID: 15745779
[TBL] [Abstract][Full Text] [Related]
3. Statin use and the risk of age related macular degeneration in a large health organization in Israel.
Shalev V; Sror M; Goldshtein I; Kokia E; Chodick G
Ophthalmic Epidemiol; 2011 Apr; 18(2):83-90. PubMed ID: 21401416
[TBL] [Abstract][Full Text] [Related]
4. [Use of statins as a form of protection against age-related macular degeneration (AMD)].
Drobek-Słowik M; Karczewicz D; Safranow K; Jakubowska K; Chlubek D
Klin Oczna; 2008; 110(1-3):50-4. PubMed ID: 18669084
[TBL] [Abstract][Full Text] [Related]
5. Statins do not decrease the risk for wet age-related macular degeneration.
Kaiserman N; Vinker S; Kaiserman I
Curr Eye Res; 2009 Apr; 34(4):304-10. PubMed ID: 19373579
[TBL] [Abstract][Full Text] [Related]
6. Recent statin use and 1-year incidence of exudative age-related macular degeneration.
Fong DS; Contreras R
Am J Ophthalmol; 2010 Jun; 149(6):955-958.e1. PubMed ID: 20346439
[TBL] [Abstract][Full Text] [Related]
7. Statin use and the five-year incidence and progression of age-related macular degeneration.
Klein R; Knudtson MD; Klein BE
Am J Ophthalmol; 2007 Jul; 144(1):1-6. PubMed ID: 17475196
[TBL] [Abstract][Full Text] [Related]
8. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Rochtchina E; Wang JJ
Am J Ophthalmol; 2007 Apr; 143(4):685-7. PubMed ID: 17386278
[TBL] [Abstract][Full Text] [Related]
9. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.
Wilson HL; Schwartz DM; Bhatt HR; McCulloch CE; Duncan JL
Am J Ophthalmol; 2004 Apr; 137(4):615-24. PubMed ID: 15059698
[TBL] [Abstract][Full Text] [Related]
10. Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.
Barbosa DT; Mendes TS; Cíntron-Colon HR; Wang SY; Bhisitkul RB; Singh K; Lin SC
Eye (Lond); 2014 Apr; 28(4):472-80. PubMed ID: 24503725
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
12. A suggested association between hypothyroidism and age-related macular degeneration.
Bromfield S; Keenan J; Jolly P; McGwin G
Curr Eye Res; 2012 Jun; 37(6):549-52. PubMed ID: 22577773
[TBL] [Abstract][Full Text] [Related]
13. The association of aspirin use with age-related macular degeneration.
Liew G; Mitchell P; Wong TY; Rochtchina E; Wang JJ
JAMA Intern Med; 2013 Feb; 173(4):258-64. PubMed ID: 23337937
[TBL] [Abstract][Full Text] [Related]
14. Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population.
Zlateva GP; Javitt JC; Shah SN; Zhou Z; Murphy JG
Retina; 2007; 27(9):1292-9. PubMed ID: 18046240
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø Study.
Erke MG; Bertelsen G; Peto T; Sjølie AK; Lindekleiv H; Njølstad I
Acta Ophthalmol; 2014 Nov; 92(7):662-9. PubMed ID: 24460653
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
17. The Question of a Role for Statins in Age-Related Macular Degeneration.
Roizenblatt M; Naranjit N; Maia M; Gehlbach PL
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469381
[TBL] [Abstract][Full Text] [Related]
18. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study.
Robman L; McNeil J; Dimitrov P; Dowrick A; Tikellis G; Nicolas C; Cameron J; Guymer R; McGrath B; McCarty C
Ophthalmic Epidemiol; 2004 Jul; 11(3):161-79. PubMed ID: 15370549
[TBL] [Abstract][Full Text] [Related]
19. Hip fracture risk in statin users--a population-based Danish case-control study.
Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
